Marks an important development in oncology, providing a treatment option for patients with AML and cholangiocarcinoma in India. Announced during AML Awareness month, highlighting Servier India’s ongoing efforts to support patients with rare and difficult-to-treat cancers Mumbai, India, June 05, 2025 – Servier India, a subsidiary of the leading French pharmaceutical Servier Group, today announced …



